Page last updated: 2024-08-18

1-naphthylamine and Breast Neoplasms

1-naphthylamine has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar-Quesada, R; Cañuelo, A; De Murcia, G; Martín-Oliva, D; Muñoz-Gámez, JA; Nuñez, MI; Oliver, FJ; Ruiz de Almodóvar, JM; Valenzuela, MT1

Other Studies

1 other study(ies) available for 1-naphthylamine and Breast Neoplasms

ArticleYear
PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    The Biochemical journal, 2005, Feb-15, Volume: 386, Issue:Pt 1

    Topics: 1-Naphthylamine; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Caspases; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Female; Genes, p53; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Naphthalimides; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Quinolones; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53

2005